NT5E and neoplasm: Indeed, regarding the effect of adenosine signaling in the defective regulation of anti-tumor response observed in preclinical tumor models (81–83), different strategies targeting CD73 ectonucleotidase are currently under extensive clinical investigation also in advanced NSCLC (46).